Calculating the intrinsic value of Thai Beverage Public Company Limited (SGX:Y92)
Key findings The forecast fair value for Thai Beverage is S$0.65 based on the 2-step free cash flow to equity Thai Beverage’s share price of...
A look at the fair value of Core Lithium Ltd (ASX:CXO)
Key findings Using 2-step free cash flow to equity, the fair value of Core Lithium is AU$0.092. With a share price of AU$0.093, Core Lithium...
Calculating the intrinsic value of AppFolio, Inc. (NASDAQ:APPF)
Key findings AppFolio’s estimated fair value is $211 based on 2-step free cash flow to equity With a share price of $245, AppFolio appears to...
Calculating the intrinsic value of Installed Building Products, Inc. (NYSE:IBP)
Key findings The projected fair value for installed building products is $220 based on 2-step free cash flow to equity Installed Building Products’ share price...
Estimate of the intrinsic value of Trican Well Service Ltd. (TSE:TCW)
Key findings The estimated fair value of Trican Well Service is CA$4.24 based on the 2-step Free Cash Flow to Equity With a share price...
Estimating the fair value of Seng Fong Holdings Berhad (KLSE:SENFONG)
Does Seng Fong Holdings Berhad’s (KLSE:SENFONG) share price in November reflect its true value? Today we will estimate the stock’s intrinsic value by taking the...
Nestlé SA (VTX:NESN) shares could be 37% below their estimated intrinsic value
Key findings The estimated fair value of Nestlé is CHF146, based on the 2-step free cash flow to equity Nestlé is estimated to be 37%...
Nestlé SA (VTX:NESN) shares could be 37% below their estimated intrinsic value
Key findings The estimated fair value of Nestlé is CHF146, based on the 2-step free cash flow to equity Nestlé is estimated to be 37%...
A look at the fair value of Siegfried Holding AG (VTX:SFZN)
I’m going to explain to you how I calculated the intrinsic value of Siegfried Holding AG (VTX:SFZN) by taking the expected future cash flows and...
ADC Therapeutics SA (NYSE:ADCT) shares could be 50% below their estimated intrinsic value
Key findings Using the 2-step free cash flow to equity, the estimated fair value of ADC Therapeutics is $6.30. ADC Therapeutics is estimated to be...